Please select an option below to help us tailor your newsletter to best suit your content interests!
West Clinic Offering New, Safer Radiation Therapy Options for Prostate Cancer Patients Prostate cancer is the most common cancer in American men, with more than 183,000 new cases diagnosed each year. More than 60,000 American men opt to treat their prostate cancer with radiation every year, but because of the proximity of the rectum… Read more »
West Clinic Offers Patients Even More Oncology Treatment Options West joins launch of new technology platform, OneR, to increase trial therapies for patients As an affiliate of OneOncology, West Clinic now has the ability to further its clinical trial offerings and oncology research knowledge by joining the launch of OneR. OneR is a… Read more »
The 5th Annual West Oncology Conference at Graceland: Advances in the Business and Science of Oncology Special Updates from COA, ASCO, ASH, ASTRO, and ESMO was a valuable forum for the presentation and discussion of new research findings. Participants were provided with an update on practice-changing data on women’s cancers, genitourinary malignancies, disparities in cancer… Read more »
West Cancer Center to get more precision treatment options from Foundation Medicine-OneOncology initiative By Jason Bolton – Data Editor, Memphis Business Journal Aug 21, 2020, 8:27am EDT A new partnership will add more genetic biodata to inform West Cancer Center’s personalized cancer treatment arsenal. OneOncology and Foundation Medicine Inc. — a molecular information company — announced Aug…. Read more »
In an effort to further promote social distancing, patients are now able to schedule certain appointments as televisits to speak with their care team from home. Talk to your care team or contact our scheduling department at 901.683.0055 to see if a televisit is right for you!
Choosing the Right Biosimilar for Cancer Care The introduction of biosimilars as anticancer therapies was preceded by a period of supportive care biosimilars. Lee S. Schwartzberg, MD, FACP, describes how he and other clinicians decide which of these agents to use. Well before biosimilar anticancer agents became available, oncologists gained familiarity using biosimilars… Read more »
Targeted treatments ‘moving the bar’ in metastatic breast cancer Research exploring novel targeted agents for patients with metastatic breast cancer is mounting and spurring excitement in the oncology field. “There really is a lot to be excited about,” Gregory A. Vidal, MD, PhD, medical oncologist at West Cancer Center and Research Institute and associate professor in… Read more »
Feeling Better During Ovarian Cancer Treatment, With the Help of Palliative Care Benefits of Palliative Care Palliative care aims to improve a patient’s quality of life during or after cancer treatment Palliative care addresses both physical and psychological symptoms It’s a more holistic approach to treating the whole person, not just their disease A… Read more »
State of the Science Summit: Treatment of Breast Cancer Chair: Lee Schwartzberg, MD, FACP Institution: West Cancer Center and Research Institute Date: Tuesday, October 29th 2019 | 5:00pm – 9:00pm Location: Hilton Memphis | 939 Ridge Lake Blvd, Memphis, TN 38120 Participants: Lee Schwartzberg, MD, FACP | West Cancer Center and Research Institute Michael Berry, MD| West Cancer Center and… Read more »
At Great Debates and Updates in GI Malignancies, nationally recognized thought leaders take opposing sides on clinical, and sometimes controversial, topics currently disrupting the practice of gastrointestinal oncology. Through comprehensive review of the latest clinical advancements in gastrointestinal malignancies, robust audience engagement, and ample discussion, participants will leave equipped with practical implications and applications to… Read more »